Marketwire -- London, UK; Brentwood, TN; 9 October 2008 - Protherics PLC (“Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, in accordance with Listing Rule 3.5.6, notifies the following details in respect of the block listing for its 1998 Savings Related Share Option Scheme:
